Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 13.27%2.55B | 18.87%1.66B | 9.73%717.21M | -10.75%3.5B | -14.55%2.25B | -14.21%1.4B | -14.68%653.59M | -9.01%3.92B | -4.78%2.64B | -9.86%1.63B |
| Refunds of taxes and levies | -51.48%6.45M | -53.18%838.23K | -46.19%429.7K | 43.56%15.67M | 28.99%13.29M | -80.58%1.79M | -90.22%798.5K | -88.99%10.91M | -84.66%10.3M | -84.81%9.22M |
| Cash received relating to other operating activities | -1.21%90.93M | -11.92%35.98M | 68.75%44.39M | 17.75%139.41M | 28.10%92.04M | -5.56%40.84M | 2.17%26.31M | -10.88%118.4M | -46.19%71.85M | -63.90%43.25M |
| Cash inflows from operating activities | 12.34%2.65B | 17.90%1.7B | 11.95%762.04M | -9.77%3.65B | -13.25%2.36B | -14.35%1.44B | -14.91%680.69M | -10.81%4.05B | -8.44%2.72B | -15.41%1.68B |
| Goods services cash paid | 4.12%1.48B | 6.51%998.49M | 4.49%461.81M | -7.43%1.95B | -5.93%1.42B | -7.67%937.49M | -14.99%441.97M | -18.67%2.11B | -20.86%1.51B | -22.53%1.02B |
| Staff behalf paid | -4.22%842.2M | -2.26%596.88M | -2.53%354.14M | -1.74%1.15B | -1.74%879.29M | -4.06%610.67M | -6.17%363.32M | 3.52%1.17B | 8.68%894.88M | 8.27%636.53M |
| All taxes paid | 12.70%84.34M | 3.90%55.2M | 25.77%33.48M | -4.25%109.1M | -11.66%74.83M | -14.52%53.13M | -21.65%26.62M | -17.38%113.95M | -20.96%84.71M | -6.39%62.16M |
| Cash paid relating to other operating activities | 9.43%211.85M | -10.02%115.85M | 11.68%76.27M | -5.41%274.49M | -10.75%193.59M | -6.73%128.76M | -19.63%68.29M | -9.41%290.18M | -18.56%216.91M | -28.70%138.05M |
| Cash outflows from operating activities | 1.91%2.61B | 2.10%1.77B | 2.83%925.7M | -5.36%3.49B | -5.11%2.56B | -6.59%1.73B | -12.26%900.21M | -11.91%3.69B | -12.82%2.7B | -14.20%1.85B |
| Net cash flows from operating activities | 118.31%37.47M | 76.15%-69.31M | 25.44%-163.67M | -54.39%165.8M | -1,250.40%-204.7M | -69.56%-290.66M | 2.90%-219.51M | 2.12%363.55M | 113.84%17.79M | 0.23%-171.42M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 5.95%563.42M | 15.85%399.46M | 39.32%334.74M | -13.94%504.72M | 40.49%531.76M | -6.46%344.8M | -33.27%240.27M | -7.35%586.46M | 9.43%378.52M | 22.04%368.6M |
| Cash received from returns on investments | -52.08%10.63M | -55.15%8.07M | -26.96%1.24M | 322.81%20.29M | 1,092.49%22.18M | 1,194.02%17.98M | 208.14%1.7M | -68.83%4.8M | -83.59%1.86M | -83.31%1.39M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | 540.57%6.65M | 3,968.24%4.21M | 806.71%773.74K | -71.34%851.32K | -8.71%1.04M | -83.49%103.37K | -42.70%85.33K | 148.60%2.97M | 46.71%1.14M | 127.30%625.95K |
| Net cash received from disposal of subsidiaries and other business units | --130.81 | --130.81 | ---- | ---- | ---- | ---- | ---- | 339.23%27.4K | 339.23%27.4K | --27.4K |
| Cash inflows from investing activities | 4.63%580.69M | 13.46%411.73M | 39.12%336.76M | -11.51%525.86M | 45.46%554.98M | -2.09%362.89M | -32.90%242.06M | -8.51%594.25M | 6.57%381.54M | 19.32%370.65M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -70.53%30.15M | -81.84%16.43M | -87.04%9.16M | -39.28%152.41M | -49.83%102.3M | -37.39%90.46M | -11.61%70.74M | -38.17%250.99M | 2.83%203.92M | 0.74%144.48M |
| Cash paid to acquire investments | 13.89%557.01M | 35.44%399.39M | 2.75%243.14M | -19.74%525.99M | 24.41%489.06M | -19.07%294.88M | -40.00%236.63M | 14.06%655.34M | 42.96%393.12M | 67.54%364.35M |
| Cash paid relating to other investing activities | ---- | ---- | ---- | --527.76K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash outflows from investing activities | -0.71%587.16M | 7.91%415.82M | -17.91%252.3M | -25.09%678.93M | -0.95%591.36M | -24.27%385.34M | -35.21%307.36M | -7.82%906.33M | 25.44%597.03M | 39.79%508.83M |
| Net cash flows from investing activities | 82.22%-6.47M | 81.79%-4.09M | 229.32%84.45M | 50.95%-153.06M | 83.12%-36.38M | 83.75%-22.45M | 42.55%-65.3M | 6.46%-312.08M | -82.72%-215.49M | -158.88%-138.18M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | -90.64%490K | ---- | ---- | 149.24%5.23M | --5.23M | --5.23M | --5.23M | --2.1M | ---- | ---- |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | -90.64%490K | ---- | ---- | 149.24%5.23M | --5.23M | --5.23M | --5.23M | --2.1M | ---- | ---- |
| Cash from borrowing | -35.52%84.85M | -27.94%54.85M | 24.97%48.65M | 8.12%273.09M | -41.19%131.6M | -34.57%76.12M | -38.92%38.93M | -55.67%252.58M | -40.18%223.79M | -55.75%116.34M |
| Cash received relating to other financing activities | -34.29%74.9M | -33.78%49M | -24.37%25M | -20.32%149M | -29.19%114M | -27.87%74M | -46.34%33.05M | -30.74%187M | -26.82%161M | -43.00%102.6M |
| Cash inflows from financing activities | -36.12%160.24M | -33.15%103.85M | -4.62%73.65M | -3.25%427.32M | -34.81%250.83M | -29.04%155.35M | -38.39%77.22M | -47.41%441.68M | -35.23%384.79M | -50.57%218.94M |
| Borrowing repayment | 52.57%182.09M | 92.18%95.58M | 46.26%57.77M | -20.71%184.98M | -44.80%119.35M | -58.66%49.74M | -24.50%39.5M | -65.56%233.3M | -62.12%216.2M | -75.18%120.32M |
| Dividend interest payment | -68.07%23.4M | -78.32%14.08M | 0.34%7.11M | -24.26%83.56M | -15.89%73.28M | 281.55%64.92M | -22.47%7.08M | 166.03%110.33M | 118.38%87.13M | -20.26%17.02M |
| -Including:Cash payments for dividends or profit to minority shareholders | -88.19%1.01M | ---- | ---- | -75.28%10.15M | -58.70%8.58M | 254.34%7M | ---- | 239.28%41.05M | 36.99%20.76M | -76.52%1.98M |
| Cash payments relating to other financing activities | -34.83%92.95M | -24.20%69M | 12.00%34.19M | -10.23%185.91M | -11.52%142.63M | -9.75%91.03M | -38.56%30.53M | -2.44%207.1M | 19.39%161.21M | 10.97%100.86M |
| Cash outflows from financing activities | -10.98%298.45M | -13.14%178.66M | 28.48%99.07M | -17.48%454.45M | -27.83%335.27M | -13.65%205.68M | -30.62%77.11M | -40.86%550.73M | -37.70%464.53M | -60.10%238.2M |
| Net cash flows from financing activities | -63.68%-138.2M | -48.64%-74.81M | -23,254.71%-25.42M | 75.13%-27.12M | -5.88%-84.43M | -161.35%-50.33M | -99.23%109.76K | -19.22%-109.05M | 47.37%-79.74M | 87.50%-19.26M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | -120.99%-162.97K | -88.59%119.5K | -101.47%-4.21K | -191.15%-1.35M | -19.01%776.53K | 128.27%1.05M | 183.05%285.67K | -71.01%1.48M | -72.67%958.82K | -72.26%458.71K |
| Net increase in cash and cash equivalents | 66.94%-107.36M | 59.14%-148.09M | 63.21%-104.63M | 71.96%-15.73M | -17.45%-324.74M | -10.35%-362.39M | 12.72%-284.42M | 12.37%-56.11M | 29.92%-276.48M | 13.03%-328.4M |
| Add:Begin period cash and cash equivalents | -1.91%808.88M | -1.91%808.88M | -1.91%808.88M | -6.37%824.61M | -6.37%824.61M | -6.37%824.61M | -6.37%824.61M | -6.78%880.71M | -6.78%880.71M | -6.78%880.71M |
| End period cash equivalent | 40.34%701.51M | 42.96%660.78M | 30.37%704.24M | -1.91%808.88M | -17.27%499.87M | -16.31%462.21M | -2.64%540.18M | -6.37%824.61M | 9.82%604.23M | -2.62%552.32M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- | -- | Zhonghui Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.